Sovran Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
3,668
-206
-5% -$16.6K 0.02% 468
2026
Q1
$314K Sell
3,874
-3,003
-44% -$288K 0.02% 444
2025
Q4
$681K Sell
6,877
-57
-0.8% -$5.54K 0.06% 290
2025
Q3
$631K Buy
6,934
+1,639
+31% +$151K 0.06% 289
2025
Q2
$469K Sell
5,295
-237
-4% -$20.1K 0.05% 323
2025
Q1
$457K Buy
5,532
+661
+14% +$59.1K 0.06% 304
2024
Q4
$415K Buy
+4,871
New +$422K 0.06% 288

Other funds holding MDT

Sovran Advisors's MDT Position: Q2 2026 in Review

Sovran Advisors reduced its Medtronic (MDT) stake by 5.3% in Q2 2026, selling an estimated $16.6K and leaving 3,668 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #468.

Sovran Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $681K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sovran Advisors held 3,668 shares of Medtronic worth $319K as of Q2 2026.
  • Sovran Advisors sold 206 Medtronic shares in Q2 2026, an estimated $16.6K.
  • Medtronic made up 0.02% of Sovran Advisors's portfolio in Q2 2026, its #468 holding.
  • Sovran Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Sovran Advisors's Medtronic position peaked at $681K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.